GIANT CELL ARTERITIS (GCA)
Clinical trials for GIANT CELL ARTERITIS (GCA) explained in plain language.
Never miss a new study
Get alerted when new GIANT CELL ARTERITIS (GCA) trials appear
Sign up with your email to follow new studies for GIANT CELL ARTERITIS (GCA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
GCA patients may soon escape Long-Term drug use
Disease control Recruiting nowThis study looks at whether people with giant cell arteritis (GCA) who are in remission can safely stop or lower their dose of tocilizumab (Actemra). About 78 adults who have been on high-dose tocilizumab for at least a year and off steroids for 3 months will either stop the drug…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 07:53 UTC
-
Could a diabetes drug and a blood pressure pill shield vasculitis patients from heart attacks?
Disease control Recruiting nowThis study tests whether two medications, dapagliflozin and bosentan, can improve blood vessel function in people with large vessel vasculitis (LVV), a condition that damages arteries and raises the risk of heart attacks and strokes. About 60 adults with stable LVV will take both…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Phase: PHASE2 • Sponsor: University of Edinburgh • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Blood test may spare PMR patients from unnecessary scans for hidden artery inflammation
Diagnosis Recruiting nowThis study looks at whether measuring a protein called thrombomodulin in the blood can help doctors know if a person with polymyalgia rheumatica (PMR) also has giant cell arteritis (GCA), a more serious condition that can cause blindness or stroke. About 78 adults over age 50 wit…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Diagnosis
Last updated May 26, 2026 07:57 UTC
-
Eye ultrasound may spot hidden artery disease
Diagnosis Recruiting nowThis study looks at whether measuring the optic nerve sheath with ultrasound can reliably diagnose giant cell arteritis (GCA), a condition that causes inflammation in blood vessels. Researchers will enroll 190 people over age 50 with suspected GCA. The goal is to see if this simp…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Phase: NA • Sponsor: Hôpital NOVO • Aim: Diagnosis
Last updated May 26, 2026 07:49 UTC
-
Blood test could end guesswork in treating arthritis and autoimmune diseases
Diagnosis Recruiting nowThis study is testing a new blood test that may help doctors choose the most effective medicine for people with rheumatic diseases like rheumatoid arthritis, lupus, and vasculitis. Researchers will take a blood sample and use it to see how a person's immune cells react to differe…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Sponsor: University of Bonn • Aim: Diagnosis
Last updated May 20, 2026 11:54 UTC
-
Steroid withdrawal relief: new study tests hydrocortisone for lingering fatigue
Symptom relief Recruiting nowThis study tests whether a low-dose hormone called hydrocortisone can relieve symptoms like fatigue and dizziness in people who have recently stopped taking steroids for giant cell arteritis or polymyalgia rheumatica. About 100 adults aged 50 and older will receive either hydroco…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Phase: PHASE4 • Sponsor: Marianne Andersen • Aim: Symptom relief
Last updated May 19, 2026 12:01 UTC
-
New scan could prevent unnecessary treatments for sudden vision loss
Knowledge-focused Recruiting nowThis study looks at two conditions that cause sudden vision loss: giant cell arteritis (GCA) and NAION. GCA is a blood vessel inflammation that needs quick treatment, while NAION does not benefit from that treatment. Researchers will use advanced PET/MRI and eye scans to find sig…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 26, 2026 07:54 UTC
-
New tools could predict relapse in common blood vessel disease
Knowledge-focused Recruiting nowThis study looks at giant cell arteritis, a condition that causes inflammation in blood vessels and is common in older adults. Researchers want to find better ways to predict who will have a relapse and how well treatment is working. They will use ultrasound scans and blood tests…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated May 26, 2026 07:23 UTC